XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)
12 Months Ended
Feb. 15, 2022
USD ($)
Dec. 31, 2021
USD ($)
Segment
shares
Dec. 31, 2020
USD ($)
shares
Mar. 28, 2022
shares
Dec. 30, 2021
shares
Dec. 29, 2021
shares
Product Information [Line Items]            
Stockholders' Equity, Reverse Stock Split   On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022.        
Common stock issued | shares   1,600,835 1,576,844   240,125,224 240,125,244
Common stock outstanding | shares   1,600,835 1,576,844   240,125,224 240,125,244
Federal insured amount   $ 250,000        
Cash balance, amount   2,160,000        
Allowance for doubtful accounts   $ 181,942 $ 165,098      
Property and equipment useful lives   5 years        
Deferred revenue   $ 2,839,838 3,724,189      
Revenue recognized   $ 3,358,578 $ 1,103,447      
Revenue recognized, percentage   90.00% 76.00%      
Remaining performance obligations   $ 10,818,000        
Remaining performance obligations, percentage   4.00%        
Product warranty description   The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue        
Product development costs   $ 469,703 $ 390,229      
Share based compensation cost   324,405 $ 405,617      
Share based compensation, incentive compensation awards   $ 83,625        
Number of operating segments | Segment   1        
Share-based Payment Arrangement, Option [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares     194,757      
Series B Preferred Stock Warrants [Member]            
Product Information [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount | shares   115,684        
Board Of Directors [Member]            
Product Information [Line Items]            
Share based compensation cost     $ 128,434      
Share based compensation, incentive compensation awards     $ 128,434      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage   24.00% 28.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage   10.00% 11.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage   10.00% 10.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage   68.00% 48.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage   23.00% 38.00%      
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier One [Member]            
Product Information [Line Items]            
Concentration risk percentage   29.00% 27.00%      
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Two [Member]            
Product Information [Line Items]            
Concentration risk percentage   11.00% 25.00%      
Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Three [Member]            
Product Information [Line Items]            
Concentration risk percentage   10.00% 12.00%      
Accounts Payable and Accrued Liabilities [Member]            
Product Information [Line Items]            
Accrued warranty reserve   $ 186,605 $ 173,365      
2023 [Member]            
Product Information [Line Items]            
Remaining performance obligations   1,663,000        
Customer Contracts [Member]            
Product Information [Line Items]            
Remaining performance obligations   411,000        
Inventory Valuation and Obsolescence [Member]            
Product Information [Line Items]            
Inventory adjustments   $ 91,379 $ 93,045      
Subsequent Event [Member]            
Product Information [Line Items]            
Proceeds from completion of an equity offering $ 22,000,000          
Common stock outstanding | shares       7,784,444